3 years ago, we laid out a bold vision for biopharma R&D: understand disease in humans + combine human & machine intelligence to discover better therapies.
With today’s AI momentum, this isn’t just a vision—it’s a roadmap. I’m all in. 🧠🤖
Today we're unveiling Dimension II: a $500M fund to support and partner with the leading builders at the vanguard of life sciences and technology.
To our entrepreneurs, past present and future: Our work is far from done. LFG.
AI has made great strides in recent years, enabling the processing of large amounts of data in a short time frame. In this publication Evotec experts review state-of-the-art #AI methods being applied to #drugdiscovery. - https://t.co/M9qh1xyYtY #researchneverstops
Hello world! I am excited to start my journey with @Evotec as of today - together with all my new colleagues and all our partners driving innovation for the benefit of patients across the world. Let’s make a it count!
Today is my last day at @McKinsey.
I joined out of curiosity and for the professional challenges, stayed for the people, and leave with amazing memories and deep friendships. Thank you all - onwards and upwards :)
New paper on how harnessing advances in science and technology can deliver transformative therapies faster while reducing the socioeconomic burden of disease.
#pipelinebuilding#socioeconomic#health4people https://t.co/ogvqMHuDqy
It is true. After the lab, 20 years at @McKinsey focused on innovation and R&D in life sciences across the globe - I will join @Evotec as Chief Business Officer (BD, tech, strategy) as of May 1. For now I will stay committed to my clients & mission but stay tuned, more to come.
What would shift to net-zero by 2050 entail? New McKinsey research lays out the six defining characteristics of the net-zero transition. Watch this video to learn more, and download the full report here: https://t.co/Tb3MsegmTb https://t.co/hVRD0Ei4hK
And here it is ... MIT's "10 Breakthrough Technologies 2021" ... an annual must-read to avoid missing the pace of innovation. mRNA obviously prominently featured. #Innovation#BioRevolution https://t.co/E0QB7ISrIC
Citing MGI's research, WEF notes that the Bio Revolution could be an enormous boon to the economy in the decades to come. #BioRevolution https://t.co/VpcOnuLE1d